Cultured skin substitutes: A review

Tissue Engineering

Volumn 2, Issue 4, 1996, Pages 255-266

  Boyce, Steven T ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; GENE PRODUCT;

ANTIGEN EXPRESSION; ARTIFICIAL SKIN; AUTOGRAFT; CELL STRUCTURE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; EPIDERMIS; FIBROBLAST; GENE THERAPY; KERATINOCYTE; MORPHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; SKIN INJURY; SKIN TRANSPLANTATION; TISSUE CULTURE CELL; VASCULARIZATION;

EID: 0030462469     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1996.2.255     Document Type: Conference Paper

References (123)

1. Gendimenico, G.J., and Mezick, J.A. Pharmacological effects of retinoids on skin cells (review). Skin Pharmacol 1(suppl 6), 24, 1993.
2. Boyce, S.T., Goretsky, M.J., Greenhalgh, D.G., Kagan, R.J., Rieman, M.T., and Warden, G.D. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann. Surg. 222(6), 743, 1995.
3. Goldberg, A.M., and Frazier, J.M. Alternatives to animals in toxicity testing (review). Scientific American 261(2), 24, 1989.
4. Vogt, P.M., Thompson, S., Andree, C., Liu, P., Breuing, K., et al. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc. Natl. Acad. Sci. U. S. A. 91(20), 9307, 1994.
5. Tompkins, R.G.,and Burke, J.F. Alternative wound coverings. In Herndon, D.N.,ed.,Total Burn Care. Philadelphia, PA: W.B. Saunders, 1996, pp. 164-172.
6. Hansbrough, J.F. Current status of skin replacements for coverage of extensive burn wounds. J. Trauma 30, S155, 1990.
7. Robson, M.C., Barnett, R.A., Leitch, I.O.W., and Hayward, P.G. Prevention and treatment of postburn scars and contracture. World J. Surg. 16, 87, 1992.
8. Burke, J.F., Yannas, I.V., Quinby, W.C., Bondoc, C.C., and Jung, W.K. Successful use of a physiologically acceptable skin in the treatment of extensive burn injury. Ann. Surg. 194, 413, 1981.
9. Boyce, S.T., and Ham, R.G. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J. Invest. Dermatol. 81 (suppl 1), 33s, 1983.
10. Green, H.,Kehinde, O., and Thomas, J. Growth of human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl. Acad. Sci. U. S. A. 76, 5665, 1979.
11. Boyce, S.T., and Ham, R.G. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J. Tiss. Cult. Meth. 9, 83, 1985.
12. Rheinwald, J.G.,and Green, H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6, 331, 1975.
13. Germain, L.,Rouabhia, M., Guignard, R., Carrier, L., Bouvard, V., and Auger, F.A. Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19(2), 99, 1993.
14. Yannas, I.V., and Burke, J.F. Design of an artifical skin. J. Basic design principles. J. Biomed. Mater. Res. 14, 65, 1980.
15. Pruitt B.A., Jr., and Levine, S. Characteristics and uses of biologic dressings and skin sustitutes. Arch. Surg. 199, 312, 1984.
16. Boyce, S.T., and Hansbrough, J.F. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 103, 421, 1988.
17. Slivka, S.R., Landeen, L., Zeigler, F., Zimber, M.P., and Bartel, R.L. Characterization, barrier function and drug metabolism of an in vitro skin model. J. Invest. Dermatol. 100(1), 40, 1993.
18. Bell, E.,Ehrlich, H.P., Sher, S., Merrill, C., Sarber, R., and Hull, B. Development and use of a living skin equivalent. Plast. Reconstr. Surg. 67, 386, 1981.
19. Parenteau, N.L.,Nolte, C.M.,Bilbo, P.,Rosenberg, M.,Wilkins, L.M.,et al. Epidermis generated in vitro: Practical consideration and applications. J. Cell Biochem. 45(3), 245, 1991.
20. Lerner, A.B., Halaban, R., Klaus, S.N., and Moellmann, G.E. Transplantation of human melanocytes. J. Invest. Dermatol. 89(3), 219, 1987.
21. Watson, S.A., Pisansarakit, P., and Moore, G.P. Sheep vibrissa dermal papillae induce hair follicle formation in heterotypic skin equivalents. Br. J. Dermatol. 131(6), 827, 1994.
22. Blume, U.,Schon, M.P.,Zouboulis, C.C.,Detmar, M.,and Orfanos, C.E. Vellus hair follicle-derived keratinocyte culture: A new experimental model in human hair research. Skin Pharmacol. 7(1-2), 27, 1994.
23. Gallico, G.G., III, O'Connor, N.E., Compton, C.C., Kehinde, O., and Green, H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 311, 448, 1984.
24. Leigh, I.M., Purkis, P.E., Navsaria, H.A., and Phillips, T.J. Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br. J. Dermatol. 117, 591, 1987.
25. Carver, N., and Leigh, I.M. Keratinocyte grafts and skin equivalents. Int. J. Dermatol. 30, 540, 1991.
26. Rouabhia, M.,Germain, L., Bergeron, J., and Auger, F.A. Successful transplantation of chimeric allogeneic-autologous cultured epithelium. Cell Transplant. 3(3), 54, 1994.
27. Rouabhia, M.,Germain, L.,Bergeron, J.,and Auger, F.A. Allogeneic-syngeneic cultured epithelia: A successful therapeutic option for skin regeneration. Transplantation 59(9), 1229, 1995.
28. Alexander, J.W., MacMillan, B.G., Law, E., and Kittur, D.S. Treatment of severe burns with widely meshed skin autograft and meshed skin allograft overlay. J. Trauma 21(6), 433, 1981.
29. Vert, M.,Mauduit, J.,and Li, S. Biodegradation of PLA/GA polymers: Increasing complexity (review). Biomaterials 15(15), 1209, 1994.
30. Burgeson, R.E.,and Nimni, M.E. Collagen types: Molecular structure and tissue distribution (review). Clin. Orthop. 282, 250, 1992.
31. Beumer, G.J.,van Blitterswijk, C.A.,and Ponec, M. Biocompatibility of a biodegradable matrix used as a skin substitute: An in vivo evaluation. J. Biomed. Mater. Res. 28(5), 545, 1994.
32. Beumer, G.J., van Blitterswijk, C.A., Bakker, D., and Ponec, M. Cell-seeding and vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA. Biomaterials 14(8), 598, 1993.
33. Nimni, M.E.,Cheung, D.,Strates, B.,Kodama, M.,and Shikh, K. Chemically modified collagen: A natural biomaterial for tissue replacement. J. Biomed. Mater. Res. 21(6), 741, 1987.
34. Livesey, S.A.,Herndon, D.N.,Hollyoak, M.A.,Atkinson, Y.H.,and Nag, A. Transplanted acellular allograft dermal matrix: Potential as a template for the reconstruction of viable dermis. Transplantation 60(1), 1, 1995.
35. Adzick, N.S.,and Lorenz, H.P. Cells, matrix, growth factors, and the surgeon: The biology of scarless fetal wound repair. Ann. Surg. 220(1), 10, 1994.
36. Adzick, N.C.,and Longaker, M.T. Scarless fetal healing: Therapeutic implications. Ann. Surg. 215, 3, 1992.
37. Auger, F.A., Guignard, R., Lopez-Valle, C.A., and Germain, L. Role and innocuity of Tisseel™, a tissue glue, in the grafting process and in vivo evolution of human cultured epidermis. Br. J. Plast. Surg. 46, 136, 1993.
38. Hansbrough, J.F., Dore, C., and Hansbrough, W.B. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised wounds. J. Burn Care Rehabil. 13, 519, 1992.
39. Hansbrough, J.F., Cooper, M.L., Cohen, R., Spielvogel, R.L., Greenleaf, G., et al. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 111(4), 438, 1992.
40. May, S.R., Gutterman, R.M., and Wainwright, J.F. Cryopreservation of skin using an insulated heat sink box stored at -70°C. Cryobiology 22, 205, 1985.
41. Yannas, I.V., Burke, J.F., Gordon, P.L., Huang, C., and Rubenstein, R.H. Design of an artificial skin. 2. Control of chemical composition. J. Biomed. Mater. Res. 14, 107, 1980.
42. Boyce, S.T., Christianson, D.J., and Hansbrough, J.F. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J. Biomed. Mater. Res. 22, 939, 1988.
43. Konstantinow, A.,Muhlbauer, W.,Hartinger, A.,and von Donnersmarch, G.G.H. Skin banking: A simple method for cyropreservation of split-thickness and cultured skin and cultured human epidermal keratinocytes. Ann. Plast. Surg. 26, 89, 1991.
44. Linden, J.V., and Favreau, T.J. Professional standards in cell and tissue processing. Cell Transplant. 4(5), 441, 1995.
45. Yannas, I.V., Burke, J.F., Orgill, D.P., and Skrabut, E.M. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 215, 174, 1982.
46. Bell, E.,Sher, S., Hull, B., Merrill, C., Rosen, S., et al. The reconstitution of living skin. J. Invest. Dermatol. 81(1), 2s, 1983.
47. Boyce, S.T., Foreman, T.J., English, K.B., Stayner, N., Cooper, M.L., et al. Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery 110, 866, 1991.
48. Thesleff, I.,Vaahtokari, A.,and Partanen, A.M. Regulation of organogenesis: Common molecular mechanisms regulating the development of teeth and other organs (review). Int. J. Dev. Biol. 39(1), 35, 1995.
49. Grant, D.S., Rose, R.W., Kinsella, J.K., and Kibbey, M.C. Angiogenesis as a componet of epithelial-mesenchymal interactions (review). EXS 74, 235, 1995.
50. DeLuca, M.,Franzi, A.,D'Anna, F.,Zicca, A.,Albanese, E.,et al. Co-culture of human keratinocytes and melanocytes: Differentiated melanocytes are physiologically organized in the basal layer of the cultured epithelium. Eur. J. Cell Biol. 46, 176, 1988.
51. Boyce, S.T., Medrano, E.E., Abdel-Malek, Z.A., Supp, A.P., Dodick, J.M., et al. Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice. J. Invest. Dermatol. 100, 360, 1993.
52. Ham, R.G., and McKeehan, W.L. Media and growth requirements. Methods Enzymol. 58, 44, 1979.
53. Boyce, S.T., Hoath, S.B., Wickett, R., and Williams, M.L. Loss of requirement for exogenous epidermal growth factor by cultured analogous of human skin. J. Invest. Dermatol. 100(4), 579, 1993.
54. Prunieras, M.,Regnier, M., and Woodley, D.T. Methods for cultivation of keratinocytes at the air-liquid interface. J. Invest. Dermatol. 81(1), 28s, 1983.
55. Regnier, M.,Caron, D., Reichert, U., and Schaefer, H. Barrier function of human skin and human reconstructed epidermis. J. Pharm. Sci. 82(4), 404, 1993.
56. Nolte, C.J., Oleson, M.A., Bilbo, P.R., and Parenteau, N.L. Development of a stratum corneum and barrier function in an organotypic skin culture. Arch. Dermatol. Res. 285(8), 466, 1993.
57. Grubauer, G.,Feingold, K., Harris, R.M., and Elias, P.M. Lipid content and lipid type as determinants of the epidermal permeabilily barrier. J. Lipid. Res. 30(1), 89, 1989.
58. Higounenc, I.,Demarchez, M., Regnier, M., Schmidt, R., Ponec, M., and Shroot, B. Improvement of epidermal differentiation and barrier function in reconstructed human skin after grafting onto athymic nude mice. Arch. Dermatol. Res. 286, 107, 1994.
59. Boyce, S.T., Supp, A.P., Harriger, M.D., Pickens, W.L., Wickett, R.R., and Hoath, S.B. Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. J. Invest. Dermatol. 107(1), 82, 1996.
60. Goretsky, M.J., Supp, A.P., Greenhalgh, D.G., Warden, G.D., and Boyce, S.T. Surface electrical capacitance as an index of epidermal barrier properties of composite skin substitutes and skin autografts. Wound Repair Regen. 3(4), 419, 1995.
61. Ponec, M.,Kempenaar, J., Weerheim, A., de Lannoy, L., Kalkman, I., and Jansen, H. Triglyceride metabolism in human keratinocytes cultured at the air-liquid interface. Arch. Dermatol. Res. 287(8), 723, 1995.
62. Bouwstra, J.A., Gooris, G.S., Weerheim, A., Kempenaar, J., and Ponec, M. Characterization of stratum corneum structure in reconstructed epidermis by X-ray diffraction. J. Lipid. Res. 36(3), 496, 1995.
63. Mak, V.H.W., Cumpstone, M.B., Kennedy, A.H., Harmon, C.S., Guy, R.H., and Potts, R.O. Barrier function of human keratinocyte cultures at the air-liquid interface. J. Invest. Dermatol. 96, 323, 1991.
64. Boyce, S.T., and Williams, M.L. Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. J. Invest. Dermatol. 101, 180, 1993.
65. Griffey, E.S., Hueneke, M., Sukkar, S., Wainwright, D., and Livesey, S.A. Production of a human in vitro reconstituted skin and grafting to a nude mouse model. Wound Repair Regen. 3(1), 92, 1995 (abstract).
66. Wainwright, D.,Madden, M., Luterman, A., Hunt, J., Monafo, W., et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J. Burn Care Rehabil. 17, 124, 1996.
67. Compton, C.C., Gill, J.M., Bradford, D.A., Regaur, S., Gallico G.G., III, and O'Connor, N.E. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. Lab. Invest. 60, 600, 1989.
68. Swope, V.B., Cornelius, J.R., Babcock, G.F., and Boyce, S.T. Flow cytometric separation of epidermal keratnocytes and melanocytes. J. Invest. Dermatol. 106(4), 882, 1996 (abstract).
69. Banks-Schlagel, S., and Green, H. Formation of epidermis by serially cultivated human epidermal cells transplanted as an epithelium to athymic mice. Transplantation 29, 308, 1980.
70. Medalie, D.A., Eming, S.A., Tompkins, R.G., Yarmush, M.L., and Krueger, G.G. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J. Invest. Dermatol. 107(1), 121, 1996.
71. Eisinger, M.,Kraft, E.R., and Fortner, J.G. Wound coverage by epidermal cells grown in vitro. In Hunt, T.K., Heppenstall, R.B., Pines, E., and Rovee, D. eds., Soft and Hard Tissue Repair. New York, Praeger Publishers, 1984, pp. 293-310.
72. Boyce, S.T., Glafkides, M.C., Foreman, T.J., and Hansbrough, J.F. Reduced wound contraction after grafting of full-thickness wounds with a collagen and chondroitin-6-sulfate (GAG) dermal skin substitute and coverage with Biobrane. J. Burn Care Rehabil. 94, 364, 1988.
73. Boyce, S.T., Greenhalgh, D.G., Kagan, R.J., Housinger, T.A., Sorrell, J.M., et al. Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers. Plast. Reconstr. Surg. 91, 632, 1993.
74. Compton, C.C., Tong, Y., Trookman, N., Zhao, H., Roy, D., and Press, W. Transforming growth factor alpha gene expression in culture human keratinocytes is unaffected by cellular aging. Arch. Dermatol. 131(6), 683, 1995.
75. Goretsky, M.J., Harriger, M.D., Supp, A.P., Greenhalgh, D.G., and Boyce, S.T. Expression of interleukin 1α, interleukin 6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice. J. Trauma 40, 894, 1996.
76. Sahuc, F.,Nakazawa, K., Berthod, F., Collombel, C., and Damour, O. Mesenchymal-epithelial interactions regulate gene expression of type VII collagen and kalinin in keratinocytes and dermal-epidermal junction formation in a skin equivalent model. Wound Repair Regen. 4(1), 93, 1996.
77. Eming, S.A.,Lee, J.,Snow, R.G.,Tompkins, R.G.,Yarmush, M.L.,and Morgan, J.R. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice: Implications for the use of genetically modified keratinocytes to modulate dermal degeneration. J. Invest. Dermatol. 105, 756, 1995.
78. Eming, S.A.,Snow, R.G.,Yarmush, M.L.,and Morgan, J.R. Targeted expression of insulin-like growth factor to human keratinocytes: Modification of the autocrine control of keratinocyte proliferation. J. Invest. Dermatol. 107(1), 113, 1996.
79. Serup, J.,and Jemec, G.B.E. eds. Noninvasive Methods and the Skin. Boca Raton, FL: CRC Press 1995.
80. Boyce, S.T., Vicanova, J., Bouwstra, J., Harriger, M.D., Supp, A.P., et al. Biochemical and biophysical analyses of epidermal barrier formation in cultured skin substitutes grafted to athymic mice. J. Invest. Dermatol. 106(4), 916, 1996 (abstract).
81. O'Connor, N.E., Mulliken, J.B., Banks-Schlagel, S., Kehinde, O., and Green, H. Grafting of burns with cultured epithelium from autologous epidermal cells. Lancet 1(8211), 75, 1981.
82. Cuono, C.,Langdon, R.,Birchall, N.,Barttelbort, S.,and McGuire, J. Composite autologous-allogeneic skin replacement: Development and clinical application. Plast. Reconstr. Surg. 80, 626, 1987.
83. Compton, C.C., Hickerson, W., Nadire, K., and Press, W. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J. Burn Care Rehabil. 14(6), 653, 1993.
84. Hansbrough, J.F., Boyce, S.T., Cooper, M.L., and Foreman, T.J. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglcan substrate. JAMA 262, 2125, 1989.
85. Hull, B.E.,Finley, R.K.,and Miller, S.F. Coverage of burns with bilayered skin equivalents: A preliminary clinical trial. Surgery 107, 496, 1990.
86. Cooper, M.L., Andree, C., Hansbrough, J.F., Zapata-Sirvent, R.L., and Speilvogel, R.L. Direct comparison of a cultured composite skin substitute containing human keratinocytes and fibroblasts to an epidermal sheet graft containing human keratinocytes on athmic mice. J. Invest. Dermatol. 101(6), 811, 1993.
87. Boyce, S.T., Supp, A.P., Harriger, M.D., Greenhalgh, D.G., and Warden, G.D. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J. Invest. Dermatol. 104(3), 345, 1995.
88. Teepe, R.G.C., Kreis, R.W., Koebrugge, E.J., Kempenaar, J.A., Vloemans, A.F., et al. The use of cultured autologous epidermis in the treatment of extensive burn wounds. J. Trauma 30, 269, 1990.
89. Boyce, S.T., and Holder, I.A. Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast. Reconstr. Surg. 92(4), 493, 1993.
90. Boyce, S.T., Warden, G.D., and Holder, I.A. Non-cytotoxic combinations of topical antimicrobial agents for use with cultured skin. Antimicrobial Agents Chemother. 39(6), 1324, 1995.
91. Munster, A.M.,Weiner, S.H.,and Spence, R.J. Cultured epidermis for coverage of burn wounds: A single-center experience. Ann. Surg. 211, 676, 1990.
92. Rue, L.W., Cioffi, W.G., McManus, W.F., and Pruitt, B.A. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J. Trauma 34(5), 662, 1993.
93. Heimbach, D.,Luterman, A.,Burke, J.F.,Cram, A.,Herndon, D.,et al. Artifical dermis for major burns: A multicenter randomized clinical trial. Ann. Surg. 208, 313, 1988.
94. Desai, M.H.,Mlakar, J.M.,McCauley, R.L.,Abdullah, K.M.,Rutan, R.L.,et al. Lack of long-term durability of cultured keratinocyte burn wound coverage: A case report. J. Burn Care Rehabil. 12, 540, 1991.
95. Boyce, S.T.,Glatter, R.,and Kitzmiller, W.J. Treatment of chronic wounds with cultured cells and biopolymers: a pilot study. Wounds 7(1), 24, 1995.
96. Phillips, T.J.,Bhawan, J.,Leigh, I.M.,Baum, H.J.,and Gilchrest, B.A. Cultured epidermal autografts and allografts: A study of differentiation and allograft survival. J. Am. Acad. Dermatol. 23, 189, 1990.
97. Kessler, D.A., Siegel, J.P., Noguchi, P.D., Zoon, K.C., Feiden, K.L., and Woodcock, J. Regulation of somatic-cell therapy and gene therapy by the Food and Drug Administration. N. Engl. J. Med. 329(16), 1169, 1993.
98. U.S. Food and Drug Administration responses from the Wound Healing Clinical Focus Group at the FDA to the Government Relations Committee of the Wound Healing Society. Scars and Stripes 4, 5, 1994.
99. Fries, R.C., and Graber, M.D. Designing medical devices for conformance with harmonized standards. Biomed. Instr. Technol. 29, 284, 1995.
100. Kauffman, J.M., and Weiler, E.D. Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturing. Quality Assurance 1(3), 213, 1992.
101. Royal, P.D. Harmonization of good laboratory practice requirements and laboratory accreditation programs. Quality Assurance 3(3), 312, 1994.
102. Williamson, J.,Snelling, C.,Clugston, P.,Macdonald, I.,and Germann, E. Cultured epithelial autograft: Five years of clinical experience with 28 patients. J. Trauma 39, 309, 1995.
103. Lazarus, G.S., Cooper, D.M., Knighton, D.R., Margolis, D.J., Pecarro, R.E., et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch. Dermatol. 130, 489, 1994.
104. Sullivan, T.,Smith, H., Kermode, J., McIver, E., and Courtemanche, D.J. Rating the burn scar. J. Burn Care Rehabil. 11(3), 256, 1990.
105. Finlay, B. The torsional characteristics of human skin in vivo. J. Biomed. Eng. 6, 567, 1971.
106. Agache, P.,Monneur, C., Leveque, J., and De Rigal, L. Mechanical properties and Young's modulus of human skin in vivo. Arch. Dermatol. Res. 269, 221, 1980.
107. Matsuzaki, K.,Kumagai, N.,Fukushi, S.,Ohshima, H.,Tanabe, M.,and Ishida, H. Cultured epithelial autografting on meshed skin graft scars: Evaluation of skin elasticity. J. Burn Care Rehabil. 16, 496, 1995.
108. Atiles, L.,Spann, K., Mileski, W., Purdue, G., Hunt, J., and Baxter, C.R. Early assessment of pediatric burns by laser doppler flowmetry. Proc. Am. Burn Assoc. 27, 10, 1995 (abstract).
109. McQuiston, B., and Whitestone, J. The application of laser surface scanning for quantifying human wound progression. Wound Repair Regen. 3(1), 78, 1995 (abstract).
110. Feather, J.W., Hajizadeh-Saffiar, M., Leslie, G., and Dawson, J.B. A portable scanning spectrophotometer using wavelenghts for the rapid measurements of skin pigments. Phys. Med. Biol. 34, 807, 1989.
111. Kollias, N., and Bager, A. Quantitative assessment of UV-induced pigmentation and erythema. Photodermatology 5, 53, 1988.
112. Wickett, R.R., Nath, V., Tanaka, R., and Hoath, S.B. Use of continuous electrical capacitance and transepidermal water loss measurements for assessing barrier function in neonatal rat skin. Skin Pharmacol. 8, 179, 1995.
113. Okah, F.A., Wickett, R.R., Pickens, W.L., and Hoath, S.B. Surface electrical capacitance as a noninvasive bedside measure of epidermal barrier maturation in the newborn infant. Pediatrics 96(4), 688, 1995.
114. Jemec, G.B., and Serup, J. The relationship between electrical capacitance and the mechanical properties of human skin in vivo. Acta. Derm. Venereol. (Stockh.) 70, 245, 1989.
115. Krueger, G.G.,Morgan, J.R.,Jorgensen, C.M.,Schmidt, L.,Li, H.L.,et al. Genetically modified skin to treat disease: Potentials and limitations. J. Invest. Dermatol. 103(5), 76s, 1994.
116. Morgan, J.R., Barrandon, Y., Green, H., and Mulligan, R.C. Expression of an exogenous growth hormone gene in transplantable human epidermal cells. Science 237, 1476, 1987.
117. Fenjves, E.S.,Gordon, D.A.,Pershing, L.K.,Williams, D.L.,and Taichman, L.B. Systematic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: Implications for epidermal function and gene therapy. Proc. Natl. Acad. Sci. U. S. A. 86, 8803, 1989.
118. Fenjves, E.S.,Smith, J.,Zaradic, S.,and Taichman, L.B. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy. Hum. Gene Ther. 5(10), 1241, 1994.
119. Lu, B.,Scott, G.,and Goldsmith, L.A. A model for keratinocyte gene therapy: preclinical and therapeutic considerations. Proc. Assoc. Am. Physicians 108(2), 165, 1996.
120. Boyce, S.T. Epidermis as a secretory tissue. J. Invest. Dermatol. 102, 8, 1994 (editorial).
121. Hilleman, M.R. History, precedent, and progress in the development of mammalian cell culture systems for preparing vaccines: Safety considerations revisited. J. Med. Virol. 31(1), 5, 1990.
122. Anderson, J.M., and Gibbons, D.F. The new generation of bichemical polymers. Biomat. Med. Devices Artifical Organs 2(3), 235, 1974.
123. Lyman, D.J. Biomedical polymers (review). Ann N.Y. Acad. Sci. 146(1), 30, 1968.